Streetbeat News

ASPI

ASP Isotopes Inc. Common Stock

Industry

Chemicals

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

ASP Isotopes Inc. (NASDAQ: ASPI) has signed a purchase agreement with a leading semiconductor company to supply highly enriched silicon-28 for next-generation semiconductors in 2024. This agreement highlights ASP Isotopes' role in advancing semiconductor technology with its proprietary technology for enriching isotopes, such as silicon-28, which is crucial for quantum computing and AI technologies. The company is also in discussions with multiple manufacturers in the semiconductor and healthcare industries for future supplies, indicating a strategic expansion into these sectors.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:01 pm

HC Wainwright & Co. analyst Heiko Ihle maintains a Buy rating on ASP Isotopes (NASDAQ:ASPI) and raises the price target from $3.25 to $5.25.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 8:30 pm

Four materials sector stocks, ASP Isotopes Inc. (ASPI), Smith-Midland Corporation (SMID), Eagle Materials Inc. (EXP), and CEMEX, S.A.B. de C.V. (CX), are considered overbought with RSI values above 70, indicating potential short-term performance issues. Recent company updates and analyst upgrades have contributed to their stock gains, but their high RSI values suggest they may face downward pressure.

Portfolio Pulse from Avi Kapoor

February 07, 2024 | 11:10 am

Three materials sector stocks, United States Lime & Minerals, Inc. (USLM), United States Steel Corporation (X), and ASP Isotopes Inc. (ASPI), are considered overbought based on their RSI values, which could signal a potential short-term decline. USLM saw a 17% stock increase despite reduced demand in some sectors, X gained 90% following an acquisition announcement by Nippon Steel, and ASPI rose 31% after a corporate update.

Portfolio Pulse from Avi Kapoor

January 25, 2024 | 11:28 am

ASP Isotopes has provided an update on its operations in Pretoria, South Africa. The company, along with its North American commercial partner RC14, began processing feedstock for enriched Carbon-14 in December 2023. ASP Isotopes anticipates generating revenue and cash flow from this product in the first half of 2024. Additionally, the company has started building its third isotope enrichment facility, which will produce Ytterbium-176 and is expected to begin operations in 2025.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 1:41 pm

HC Wainwright & Co. analyst Heiko Ihle has initiated coverage on ASP Isotopes (NASDAQ:ASPI) with a Buy rating and set a price target of $3.25.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 11:36 am

ASP Isotopes Inc. has signed an MOU with a second US-based SMR company to develop a HALEU production facility, aiming to meet the growing demand for nuclear fuel. The Quantum Enrichment process, developed by ASP Isotopes and its subsidiary Quantum Leap Energy LLC, is expected to lower production costs and support the operation of small modular reactors (SMRs). With no current Western producers of HALEU in commercial quantities, ASP Isotopes anticipates a significant market opportunity, with potential customer interest exceeding $30 billion. The company plans to finance the project through customer pre-orders and partnerships.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:17 pm

ASP Isotopes has entered into a strategic relationship with PET Labs Pharmaceuticals for the distribution of medical isotopes. The partnership is expected to enhance the distribution and availability of these isotopes, which are crucial in medical imaging and cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 5:54 am

ASP Isotopes has announced a private placement of 9 million shares at a price of $0.9105 per share, raising approximately $8 million. This has led to a rise in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 2:16 pm

ASP Isotopes Inc. (NASDAQ:ASPI) has announced a private placement of approximately 9 million shares of its common stock at a price of $0.9105 per share, expected to generate around $8 million in gross proceeds. The placement was oversubscribed and priced 'At the Market' under NASDAQ rules. The Tees River Critical Resources Fund intends to take a significant percentage of the placement, increasing its total ownership to around 14%. The proceeds will be used for working capital and other general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:22 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.